COMMUNIQUÉS West-GlobeNewswire

Cosmos Health Launches Subscription Model
10/07/2026
Subscription model already launched with NOOR Collagen in the United States Early data shows a repeat purchase rate above 60% at high margins in excess of 50% Model is designed to drive stronger loyalty, greater [...]
Communiqué de presse : Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable
10/07/2026
Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable Sarclisa Escena administrée à l’aide de l’injecteur [...]
Study Results of Orelabrutinib in Patients with SLE Published in the Journal of Autoimmunity
10/07/2026
BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), today announced that the Journal of Autoimmunity has published results from a clinical study evaluating orelabrutinib, a BTK (Bruton [...]
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
10/07/2026
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena administered via the CirCLIQ ® on-body injector (OBI) offers a treatment [...]
FDA Proposes Rule to Modernize Drug Manufacturing Registration
10/07/2026
Proposed rule would streamline registration for advanced distributed manufacturers and increase visibility into foreign drug supply sources Silver Spring, MD, July 10, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug [...]
BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
10/07/2026
NETANYA, Israel, July 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a company focused on defense, security, and critical infrastructure technologies, today announced that its [...]
Frishantic Launches Vitamin D3 K2 5000 IU Supplement for Indoor-Heavy Lifestyles
10/07/2026
A one-daily softgel formula designed to support bone health, normal immune function, and daily wellness for adults navigating modern indoor routines. NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- Frishantic , a wellness [...]
Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
10/07/2026
$4 million upfront with up to approximately $7.7 million of potential additional gross proceeds upon the exercise in full of warrants in cash SARASOTA, FLA., July 10, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: [...]
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
10/07/2026
Aggregate cash dividend of an estimated $16.5 million, or an estimated $0.38 per share NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its [...]
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
10/07/2026
Advances progress towards planned Nasdaq uplisting POMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
10/07/2026
Taipei, TAIWAN, July 10, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and [...]
Grifols deaths and harm: Patient safety & options for accountability
10/07/2026
TORONTO, July 10, 2026 (GLOBE NEWSWIRE) -- Will Trial Lawyers and the Ontario Health Coalition invite members of the media to attend a press conference regarding patient safety issues related to Grifols, one of the [...]
Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials
10/07/2026
Interview Highlights Thompson's Entrepreneurial Vision and Kraig Labs' Mission to Bring Spider Silk to Commercial Scale ANN ARBOR, Mich., July 10, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB [...]
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
10/07/2026
Singapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq [...]
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
10/07/2026
Company to host scientific workshop featuring emerging eMTBR-Tau and BD-pTau217 research data for Alzheimer’s disease detection and staging FREMONT, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. ( [...]
UREVO Wins Red Dot Award 2026 for AI-Powered Wireless Recovery Boots
10/07/2026
ESSEN, Germany, July 10, 2026 (GLOBE NEWSWIRE) -- Smart wellness innovator UREVO has won the Red Dot Award: Product Design 2026 in the Innovative Design category for its AI-Powered Wireless Recovery Boots . The honor [...]
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
10/07/2026
Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China ADELAIDE, Australia, July 10, 2026 (GLOBE NEWSWIRE) -- Avance [...]
No easy answers: European research consortia take on major challenges
10/07/2026
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health [...]
MindRank Announces $52 Million Series B Financing
10/07/2026
Funding to advance MindRank’s AI-native drug R&D engine and innovative pipeline, including MDR-001, an oral small-molecule GLP-1 receptor agonist in Phase III clinical development in China HANGZHOU, China, July 09, [...]

Pages